Navigation Links
CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends
Date:2/12/2008

treatment is playing in reshaping lung cancer care. In fact, during the meeting a majority of the institutions present expressed strong interest in the prospective clinical study that is being led by M. D. Anderson Cancer Center in Houston comparing treatment outcomes with the CyberKnife System versus surgery in early-stage, operable lung cancer.

Along with the enthusiasm around CyberKnife extracranial treatment results, the System remains a widely accepted tool in the treatment of brain tumors. A data comparison of patients with acoustic tumors, treated by either CyberKnife or Gamma Knife radiosurgery demonstrated superior hearing preservation in the patients treated with the CyberKnife System.

"This year's CyberKnife Users' meeting featured clinical data that continue to support the growing usage of CyberKnife technology not only in cancer care, but also the treatment of pain disorders and psychological illnesses," said Eric P. Lindquist, senior vice president and chief marketing officer of Accuray Incorporated. "The meeting provided a forum for data sharing amongst some of the biggest leaders in the medical field, in an effort to provide the most safe, effective and comfortable care for patients."

Emerging CyberKnife treatment applications highlighted at the meeting demonstrated promising results treating patients with breast cancer, bone cancer, kidney cancer and various pain syndromes. Centers continue to explore these applications in the hopes of providing less invasive treatment options to their patients.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non- invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. T
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Instant JChem 2.0 Released: Instant JChem Personal Free for All Users
2. Consumer Advocates Praise Interstate Stem Cell Open Meeting Decision
3. CardioDynamics Provides 2007 Shareholder Meeting Update
4. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
7. Sinovac Announces Postponement of Annual General Meeting
8. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
9. Argonne scientist to give the plenary talk at Royal Society of Chemistry meeting on nanoalloys
10. ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
11. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...TEO, Calif., Nov. 6 ,... transfer of Qutenza(TM) E.U. Marketing Authorizat...ant progress in commercial readiness activities E...r Director, Marketing; and Director, Commercial Op...s director and Audit Committee chairman , U...
(Date:11/6/2009)... The agenda for Arrowhead’s 201...hich is set to take place on February 22-24, 2010 ... day conference we will highlight key issues in fo... share their experiences. , ... agenda for Arrowhead’s 2010 Personalized M...
(Date:11/5/2009)...PANY, N.J., Nov. 5 DSM Pharmaceuti...nufacturing alliance with Galenix, Saint Jean D,Il...rcial scale manufacturing partner for Galenix comm...alenix will collaborate on business development op...hnologies, based on the strength of Galenix in dru...
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...fe Sciences,announced today that Richard Evans has...sibility will be providing advisory services to co... as well as selected investment,assignments in cap...ted,drug analyst, he will also have responsibility... in the capital markets area. "Richard brings us ...
... Presentations Accepted to Meeting, CAMBRIDGE, Ma...oday announced that 23 presentations will showcase...ts antibiotic drug discovery,platform at the upcom...robial Agents and Chemotherapy (ICAAC), taking pla... Ph.D., Chief Scientific Officer of Targanta Thera...
...al Partners and Versant Ventures Lead ...DISON, Wis., Sept. 12 OpGen, Inc., today announce...ity financing. The round,was led by CHL Medical Pa...ures, with previous investor Mason Wells also part...ecome chairman of the Board of,Directors and will ...
Other Biology Technology:Senior Research Analyst Richard Evans Joins AVOS Life Sciences 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 2Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 3Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 4Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 5Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 6Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting 7OpGen Announces $23.6 Million Series A Financing 2OpGen Announces $23.6 Million Series A Financing 3
(Date:11/9/2009)...s have had their hands tied because more than half...a protein called p53. As a critical anti-cancer wa...erations within cells. When cells lose p53, tumors..., These tumors might be tough, but they,re not in...rbor Laboratory (CSHL). The chink in the tumors, a...
(Date:11/9/2009)...has inspired a 3.2m, three-year research project t...f security, energy and the environment. The Univer...y QinetiQ have just signed a collaborative contrac...ing physical sciences research. , Over the next...ity of Exeter and QinetiQ will work together to de...
(Date:11/9/2009)...utritionist whose research was instrumental in add...fants and Children (WIC) food subsidy will receive...nding achievement in the field of maternal-fetal n...fessor in the Department of Community Health Scien...chool of Public Health, will receive the award to...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 1Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 2Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 3VA Awards 243 7 Million for New Hampshire Veterans Home 48212 1HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1
... the University of Wisconsin-Madison is using musi... species in the state. , "Research shows music ...g memory, emotion, attitudes, and even behavior," ...es communication at UW-Madison and environmental c...w, who directed the project, recruited a group of ...
...008 SRI International announced today that it has ...s grant from the Bill & Melinda Gates Foundation. ...h research project conducted by Krishna Kodukula, ...enter for Advanced Drug Research (CADRE) in Shenan...ociate director of Proteomics and Protein Biochemi...
...he University of Houston to use technologies with ...tools that will help doctors and technicians bette...d neck cancer. , Dr. Ali Kamrani, founding direct...ory at UH and a former auto industry researcher, i...r and deputy research director of radiation physic...
Other Biology News:SRI International receives $100,000 Grand Challenges Explorations grant 2From cars to cancer: UH professor employs auto industry tools for tumor therapy 2From cars to cancer: UH professor employs auto industry tools for tumor therapy 3From cars to cancer: UH professor employs auto industry tools for tumor therapy 4
Customized Competent E. coli. from Molecular Cloning Laboratories (MCLAB)
Fluorescent Standards Red Standard from Invitrogen
X-Gal from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Oligodendrocyte Marker O1 Monoclonal Antibody, Unconjugated, Clone O1 from R&D Systems
Biology Products: